Author(s): Evans K
Abstract Share this page
Abstract An increasing number of people with type 1 diabetes mellitus are using insulin pump therapy, also known as continuous subcutaneous insulin infusion therapy (CSII). Most patients using pumps are safest remaining on CSII if admitted to hospital, unless incapacitated. This review provides the generalist physician with a framework to guide the management of such patients, although one should always seek specialist diabetes advice where available.
This article was published in Clin Med (Lond)
and referenced in Journal of Nursing & Care